COFOE MEDICAL (01187.HK): 2.60 million A shares bought back
NewTimeSpace News: On 2 November 2026, Cofoe Medical Technology Co., Ltd. (stock code: 01187) published an overseas regulatory announcement setting out its A-share buyback update filed on the Shenzhen Stock Exchange and CNINFO. The buyback, approved by the board on 26 June 2026 and by an extraordinary general meeting on 20 July 2026, uses its own funds and a special buyback loan and is conducted on-market, with a size of RMB 100 million to RMB 200 million.
At the price cap of RMB 69.66 per share, the plan covered 1,435,544 to 2,871,088 shares, or 0.61% to 1.22% of total share capital; the cap was adjusted to RMB 69.09 after the 2026 interim dividend. As at 31 October 2026, the company had bought back 2,596,900 A shares, or 1.24% of its A-share capital, at RMB 48.23 to RMB 54.68 per share, for RMB 134,221,894.20 excluding fees.
- HK Recently Listed Stocks Watch | COFOE MEDICAL (01187.HK): Lock-up Period on Cornerstone Investors' 9.65 Million H Shares to Expire on Nov 5
- COFOE MEDICAL (01187.HK): Controlling Shareholder Pledges 8m A Shares; Cumulative Pledge at 6.78% of Total Share Capital
- COFOE MEDICAL (01187.HK): Cuts A-share Buyback Price Cap to RMB 69.09/share After Interim Dividend
- COFOE MEDICAL (01187.HK): Addresses Rationale for A-Share Buyback and H-Share Controlling Shareholder Increase; Seven Philips-Licensed Categories Gearing for Launch
- COFOE MEDICAL(01187.HK) will spend CNY 21.53 million to repurchase 408.7 thousand shares on Jul 23, 2026
